Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
You will find anomalies on each site you visit i.e., ADVFN may show buys/sells not shown here. I think it comes down to which exchange was used and access of information. Also, some people complain that their buy was shown as a sell and forget that each trade is both a buy and sell and shown red or blue according to the market direction at the second its traded.
Massive difference between broker ratings here, Jeffries, who are always cautionary, with a hold at 650 and HSBC who have an optimistic buy target of 925. Personally I thought yesterdays trading statement was OK with YOY growth for the group +6.6%. At least with the purchase of Worldstores DNLM are looking to hedge potential shortfalls in store with online trading. A mid range broker target of 787 would appear be a good punt IMO.
Sports are making some progress and good luck to them but SPD is fundamentally in better shape with a NAV six times that of JD, lets hope they have sales to match.
81% held by institutional investors who appear to be here for the long haul. Incomes down but NAV is up and this is more like an investment trust than a company. A little breaking news could see this back over 400 IMO, any other opinions out there?
News below might be responsible for today's increase? Sheffield-based WANdisco is using its expertise to support a European Union (EU) funded initiative which could make it easier for doctors to spot the early signs of dementia, a disease which killed more than 61,000 people in England and Wales last year. A WANdisco spokesman said: “Dementia develops as a result of the interaction of genetic, non-genetic and environmental factors. “Large quantities of the behavioral, genetic, environmental and clinical data relating to those factors is already being generated in laboratories all over the world." “Until recently, it has been impossible to store and process such massive and diverse data sets.” The University of Sheffield’s Center for Computational Imaging & Simulation Technologies in Biomedicine has started to analyse this data with WANdisco’s Active Transactional Data Replication technology. This enables large volumes of data to be moved between eight different cloud providers, so it can be analysed by more than 950 applications. The data is then used in a series of computer platforms available throughout the EU. The first is the clinical research platform Multix, which allows researchers to collate large amounts of information such as MRI scans, physiological data and patient histories. The WANdisco spokesman added: “The data from Multix can then be incorporated into a patient care platform or - PCP - which allows doctors to input patient data, and take advantage of all the knowledge already created by Multix.
If SPD was re-branded 'Leisure attire for gentle folk' or even 'Chav's are us' the share price would go up 40%. The media has created a stigma that is difficult to shake but the bottom line is this company makes money and is way oversold IMO. Perhaps MA could change his name, I'm sure there would be lots of suggestions, or better still sell the company.
..results for the year so far, rental occupancy up, price per square foot up and year to date revenue up 8%. The only fly in the ointment is the CEO who has to add 'significant uncertainties remain around the UK's economic outlook' and that's the statement that ShareCast news picks up on! Well I've got news for Mr Gibson, Mark Carney et al, Brexit or no Brexit there will always be uncertainties about the future, try concentrating on whats happening now.
Me too, I guess tech/pharma shares are having a slow time in general just look at IVO. Recent news is highlighting the strength of IPO's portfolio and when the market does take notice I'm sure we will all benefit. A good time to top up IMO
Looking at FT peer analysis for IPF they are generating a smaller income from their revenue than their peers and have too many employees for their size (market cap). A little restructuring would go along way here and I'd guess a bounce is on the cards, looks a good time to buy in IMO. http://markets.ft.com/data/equities/tearsheet/profile?s=IPF:LSE
I bought in at £36 after reading the interim results which I thought would see WTB back over the £40 mark but I did not factor in the pessimistic outlook due to Brexit that is causing negativity across the market. As you say, the reality paints a different picture where your lucky to get a seat at my local Costa and our Premier Inn is booming. I would hope WTB has hit the bottom by now and long term it will recover IMO. You never know we might see a decent Santa Rally this year as many stocks are trading below par.
IBM to launch four new data centers in UK. According to news articles, in IBM's third quarter, cloud revenue grew to $12.7 billion. More good news for Wandisco who appear to be back on track, following the recent internal power struggle, with some decent contracts.
Totally agree with Jurado here, IP Group have stakes in some nice little companies any of which could make some great returns. Just saw an alert for Ceres, IPO are increasing their stake by about 25% and with their results due out next month that could be interesting.
Just shows how crazy the market is when Oil and Mining companies making huge losses are going up while decent companies like this with a solid set of results go down. Profit up 17.5% and a divi of 6% at current share price, there's a lot of companies would sacrifice their CEO for the same results this year.